FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:LRP1-MCRS1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: LRP1-MCRS1
FusionPDB ID: 49750
FusionGDB2.0 ID: 49750
HgeneTgene
Gene symbol

LRP1

MCRS1

Gene ID

10438

10445

Gene nameC1D nuclear receptor corepressormicrospherule protein 1
SynonymsLRP1|Rrp47|SUN-CoR|SUNCOR|hC1DICP22BP|INO80Q|MCRS2|MSP58|P78
Cytomap

2p14

12q13.12

Type of geneprotein-codingprotein-coding
Descriptionnuclear nucleic acid-binding protein C1DC1D DNA-binding proteinC1D nuclear receptor co-repressornuclear DNA-binding proteinsmall unique nuclear receptor co-repressorsmall unique nuclear receptor corepressormicrospherule protein 158 kDa microspherule proteinINO80 complex subunit JINO80 complex subunit Qcell cycle-regulated factor (78 kDa)cell cycle-regulated factor p78
Modification date2020031320200320
UniProtAcc

Q9NZR2

Main function of 5'-partner protein: FUNCTION: Potential cell surface proteins that bind and internalize ligands in the process of receptor-mediated endocytosis.

Q96EZ8

Main function of 5'-partner protein: FUNCTION: Modulates the transcription repressor activity of DAXX by recruiting it to the nucleolus (PubMed:11948183). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). Putative regulatory component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. May also be an inhibitor of TERT telomerase activity (PubMed:15044100). Binds to G-quadruplex structures in mRNA (PubMed:16571602). Binds to RNA homopolymer poly(G) and poly(U) (PubMed:16571602). {ECO:0000269|PubMed:11948183, ECO:0000269|PubMed:15044100, ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:20018852}.
Ensembl transtripts involved in fusion geneENST idsENST00000243077, ENST00000338962, 
ENST00000553277, ENST00000553446, 
ENST00000554174, 
ENST00000357123, 
ENST00000547182, ENST00000343810, 
ENST00000546244, ENST00000550165, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score23 X 27 X 12=74524 X 5 X 3=60
# samples 265
** MAII scorelog2(26/7452*10)=-4.84104414591318
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/60*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: LRP1 [Title/Abstract] AND MCRS1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: LRP1 [Title/Abstract] AND MCRS1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)LRP1(57604662)-MCRS1(49953604), # samples:1
Anticipated loss of major functional domain due to fusion event.LRP1-MCRS1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LRP1-MCRS1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LRP1-MCRS1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
LRP1-MCRS1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneMCRS1

GO:0043981

histone H4-K5 acetylation

20018852

TgeneMCRS1

GO:0043982

histone H4-K8 acetylation

20018852

TgeneMCRS1

GO:0043984

histone H4-K16 acetylation

20018852

TgeneMCRS1

GO:1904751

positive regulation of protein localization to nucleolus

16571602



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:57604662/chr12:49953604)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across LRP1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across MCRS1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000243077LRP1chr1257604662-ENST00000546244MCRS1chr1249953604-1419913382442138604472
ENST00000243077LRP1chr1257604662-ENST00000343810MCRS1chr1249953604-1418413382442138604472
ENST00000243077LRP1chr1257604662-ENST00000550165MCRS1chr1249953604-1414113382442138604472

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000243077ENST00000546244LRP1chr1257604662-MCRS1chr1249953604-0.0054772150.9945228
ENST00000243077ENST00000343810LRP1chr1257604662-MCRS1chr1249953604-0.0055013580.99449867
ENST00000243077ENST00000550165LRP1chr1257604662-MCRS1chr1249953604-0.0056344550.9943656

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for LRP1-MCRS1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
LRP1chr1257604662MCRS1chr1249953604133824314CLPGFLGDRCQYQLMVADRRQKREIR

Top

Potential FusionNeoAntigen Information of LRP1-MCRS1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LRP1-MCRS1_57604662_49953604.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LRP1-MCRS1chr1257604662chr124995360413382HLA-B14:02DRCQYQLMV0.99520.7682716
LRP1-MCRS1chr1257604662chr124995360413382HLA-B14:01DRCQYQLMV0.99520.7682716
LRP1-MCRS1chr1257604662chr124995360413382HLA-A02:04FLGDRCQYQL0.96430.5632414
LRP1-MCRS1chr1257604662chr124995360413382HLA-A02:17FLGDRCQYQL0.95260.6274414
LRP1-MCRS1chr1257604662chr124995360413382HLA-A02:19FLGDRCQYQL0.87910.6625414
LRP1-MCRS1chr1257604662chr124995360413382HLA-C08:15LGDRCQYQL0.99970.9804514
LRP1-MCRS1chr1257604662chr124995360413382HLA-B73:01DRCQYQLMV0.97070.7466716
LRP1-MCRS1chr1257604662chr124995360413382HLA-B39:12DRCQYQLMV0.95410.7416716
LRP1-MCRS1chr1257604662chr124995360413382HLA-B73:01DRCQYQLMVA0.98210.8502717
LRP1-MCRS1chr1257604662chr124995360413382HLA-C08:02LGDRCQYQL0.99970.9804514

Top

Potential FusionNeoAntigen Information of LRP1-MCRS1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LRP1-MCRS1_57604662_49953604.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0301YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0301QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0301CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0303YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0303QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0303CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0305YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0305QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0305CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0307YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0307QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0307CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0310YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0310QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0313YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0313QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0313CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0315YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0315QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0315CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0318YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0318QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0318CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0320YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0320QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0320CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0322YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0322QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0322CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0324YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0324QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0324CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0326YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0326QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0326CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0328YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0328QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0328CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0330YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0330QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0330CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0332YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0332QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0332CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0334YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0334QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0334CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0336YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0336QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0336CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0340YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0340QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0340CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0344YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0344QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0344CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0346YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0346QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0346CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0348YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0348QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0348CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0350YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0350QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0350CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0352YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0352QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0352CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0354YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0354QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-0354CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1107YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1107QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1107CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1121QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1159QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1186QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1186YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1186CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1316QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1316YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1316CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1319QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1327QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1327CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1327YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1341QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1341YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1341CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1353QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1361QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1361YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1361CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1371QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1371YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1371CQYQLMVADRRQKRE924
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1396QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1396YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1421YQLMVADRRQKREIR1126
LRP1-MCRS1chr1257604662chr124995360413382DRB1-1421QYQLMVADRRQKREI1025
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0101RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0101DRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0102RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0102DRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0103RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0104RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0104DRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0105RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0105DRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0108NRCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0108NDRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0111RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0113RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0113DRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0114RCQYQLMVADRRQKR823
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0114DRCQYQLMVADRRQK722
LRP1-MCRS1chr1257604662chr124995360413382DRB5-0203RCQYQLMVADRRQKR823

Top

Fusion breakpoint peptide structures of LRP1-MCRS1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2719GDRCQYQLMVADRRLRP1MCRS1chr1257604662chr124995360413382

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of LRP1-MCRS1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2719GDRCQYQLMVADRR-7.15543-7.26883
HLA-B14:023BVN2719GDRCQYQLMVADRR-4.77435-5.80965
HLA-B52:013W392719GDRCQYQLMVADRR-6.80875-6.92215
HLA-B52:013W392719GDRCQYQLMVADRR-4.20386-5.23916
HLA-A11:014UQ22719GDRCQYQLMVADRR-7.5194-8.5547
HLA-A11:014UQ22719GDRCQYQLMVADRR-6.9601-7.0735
HLA-A24:025HGA2719GDRCQYQLMVADRR-7.52403-7.63743
HLA-A24:025HGA2719GDRCQYQLMVADRR-5.82433-6.85963
HLA-B27:056PYJ2719GDRCQYQLMVADRR-3.28285-4.31815
HLA-B44:053DX82719GDRCQYQLMVADRR-5.91172-6.94702
HLA-B44:053DX82719GDRCQYQLMVADRR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of LRP1-MCRS1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
LRP1-MCRS1chr1257604662chr1249953604414FLGDRCQYQLGCTTCCTGGGCGACCGCTGCCAGTACCAGC
LRP1-MCRS1chr1257604662chr1249953604514LGDRCQYQLTCCTGGGCGACCGCTGCCAGTACCAGC
LRP1-MCRS1chr1257604662chr1249953604716DRCQYQLMVGCGACCGCTGCCAGTACCAGCTGATGG
LRP1-MCRS1chr1257604662chr1249953604717DRCQYQLMVAGCGACCGCTGCCAGTACCAGCTGATGGTGG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
LRP1-MCRS1chr1257604662chr12499536041025QYQLMVADRRQKREIGCCAGTACCAGCTGATGGTGGCTGACCGGCGCCAGAAGCGAGAGA
LRP1-MCRS1chr1257604662chr12499536041126YQLMVADRRQKREIRAGTACCAGCTGATGGTGGCTGACCGGCGCCAGAAGCGAGAGATTC
LRP1-MCRS1chr1257604662chr1249953604722DRCQYQLMVADRRQKGCGACCGCTGCCAGTACCAGCTGATGGTGGCTGACCGGCGCCAGA
LRP1-MCRS1chr1257604662chr1249953604823RCQYQLMVADRRQKRACCGCTGCCAGTACCAGCTGATGGTGGCTGACCGGCGCCAGAAGC
LRP1-MCRS1chr1257604662chr1249953604924CQYQLMVADRRQKREGCTGCCAGTACCAGCTGATGGTGGCTGACCGGCGCCAGAAGCGAG

Top

Information of the samples that have these potential fusion neoantigens of LRP1-MCRS1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCLRP1-MCRS1chr1257604662ENST00000243077chr1249953604ENST00000343810TCGA-DX-AB2G-01A

Top

Potential target of CAR-T therapy development for LRP1-MCRS1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to LRP1-MCRS1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to LRP1-MCRS1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource